Enanta CEO Jay Luly to retire by February 2027
ENTA•Enanta Pharmaceuticals CEO Jay R. Luly will retire by February 1, 2027, after 23 years leading the company. The board has begun a successor search, and Luly is expected to advise through the rest of 2027; Tara L. Kieffer was promoted to chief operating officer.
1. Leadership transition
Enanta Pharmaceuticals President and CEO Jay R. Luly will retire by February 1, 2027, following 23 years leading the company. The board has launched a search for his successor, considering internal and external candidates, and Luly is expected to serve as a strategic advisor for the remainder of 2027.
2. New operating role
Tara L. Kieffer, previously chief product strategy officer, was promoted to the newly created chief operating officer role.




